Angelica Keiskei Chalcone and Its Effect on Microvessel Density and VEGF Expression of Mice Hepatocarcinoma Cells

Zi Chao Li,Xiao Wen Li,Jian Ping Wang,Jin Yi Zhong

DOI: https://doi.org/10.4028/www.scientific.net/amr.1061-1062.223

2014-01-01

Advanced Materials Research

Abstract:To study the effect of Angelica keiskei chalcone (AC) on microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression on mice hepatocarcinoma cells. Fifty mice were inoculated with hepatocarcinoma H22 cells and divided into 5 groups. Group one to three were administered orally with AC by 5, 25 and 50 mg/kg/d, respectively. Group four was given Endostar 4mg/kg/d by intraperitoneal injection and tumor control group (group five) was given with normal saline. All mice were sacrificed after 10 days. The proliferation activity of hepatocarcinoma cells was determined by methy tetrazolium (MTT) assay, and the levels of the MVD and VEGF protein expression were detected by immunohistochemistry method. The AC inhibitory rates for tumor size were 4.20%, 30.47% and 39.42% at AC treatment dose of 5, 25, and 50 mg/kg, respectively. The average MVD count was 14.2, 11.2 and 8.5 at treatment dose of 5 mg/kg, 25 mg/kg and 50 mg/kg AC, respectively. The protein levels of VEGF in mice treated with 25 mg/kg and 50 mg/kg AC were significantly decreased. The results showed that AC could inhibit tumor angiogenesis effectively and the inhibition mechanism might be associated with the down-regulation of VEGF.